The Food and Drug Administration yesterday delivered a split decision on GSK’s blood cancer drug Blenrep, approving its use ...
Ultimately, the collaboration is focused on speeding up progress toward a safer and more resilient food system. As Corbion's ...
Vulcan Post on MSN
From lab to market: How this MRANTI Sandbox is accelerating M’sian biotech breakthroughs
MRANTI launches new Biotechnology Sandbox to help local researchers fast-track solutions from lab to market. Here are the ...
YouTube on MSN
Automated Food Delivery System In a Restaurant
Explore the future of dining with our video on the automated food delivery system in a restaurant. Discover how this ...
Telehealth companies that have seized on the boom in weight loss drugs are playing a bigger role not just in treating patients with obesity, but also shaping how the medical mainstream understands ...
Novartis will pay $72 a share in cash for the biotechnology company, representing a premium of 46% to Avidity’s closing price ...
(Oct 27): Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc in a deal valued at US$12 billion, making ...
On October 2, Novonesis opened the doors of its North American headquarters in Franklinton inviting over 300 high school ...
Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (≥2L) squamous cell anal carcinoma (SCAC) relative to 13.8% for the FDA-approved 2L treatment The median duration of response ...
NEW YORK] Novartis agreed to buy biotechnology company Avidity Biosciences in a deal that values it at US$12 billion, ...
Loopworm’s Ankit Alok Bagaria explains why silkworm pupae could transform pet food as a sustainable, nutritious and scalable ...
Pharmaceutical Technology on MSN
Ipsen to buy French biotech company ImCheck Therapeutics
Ipsen is set to purchase all issued and outstanding shares of the French biotech company ImCheck Therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback